About Sherri-Ann Burnett-Bowie, MD, MPH
Sherri-Ann Burnett-Bowie MD, MPH is an Associate Professor of Medicine at Harvard Medical School and a clinical investigator in the Massachusetts General Hospital Endocrine Unit, where her research focuses on the epidemiology of menopause and clinical trials of treatments for osteoporosis. She cares for patients seen at the Mass General Endocrine Associates and the Mass General Bone Density Center.
Clinical Interests:
- Adrenal disorders
- Adrenal nodules
- Hypercalcemia
- Hyperthyroidism
- Hypocalcemia
- Hypophosphatemia
- Hypothyroidism
- Kidney stones
- Osteoporosis
- Vitamin D deficiency
Treats:
- Adult
Locations
Mass General Endocrinology: Endocrine Associates
55 Fruit St.
Wang Ambulatory Care Center
Suite 730S
Boston, MA 02114
Phone: 617-726-8720
Medical Education
- MD, University of Pittsburgh School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid NY
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Burnett-Bowie's research is focused on skeletal and non-skeletal consequences of vitamin D deficiency, and clinical trials of treatments for osteoporosis.
Publications
-
Select Publications:
- Burnett, SM, S Gunawardene, FR Bringhurst et al. Regulation of c-terminal and intact FGF23 by dietary phosphate in men and women. JBMR 2006.
- Burnett-Bowie, SM , BZ Leder, MP Henao et al. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. CJASN 2012.
- Mitchell, DM, MP Henao, JS Finkelstein, SM Burnett-Bowie. Prevalence & predictors of vitamin D deficiency in healthy adults. JCEM 2012.
- Tsai, JN, Uihlein, AV, H Lee et al. Teriparatide & denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 2013
- Finkelstein , JS, H. Lee, SM Burnett-Bowie et al. Gonadal steroids & body composition, strength, and sexual function in men. NEJM 2013